Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Schedule of financial assets and liabilities measured and recognized at fair value

Financial assets and liabilities measured and recognized at fair value are as follows:

	June 30, 2022
	Total		Level 1		Level 2		Level 3
Assets:
Money market funds	$	30,783	$	30,783	$	—	$	—
Convertible promissory note	4,653		—		—		4,653
Embedded derivative asset in convertible promissory note	1,027		—		—		1,027
Investment in Tyme	2,800		2,800		—		—
Liability:
Foreign currency exchange contracts	685		—		685		—

	December 31, 2021
	Total		Level 1		Level 2		Level 3
Assets:
Money market funds	$	57,357	$	57,357	$	—	$	—
Convertible promissory note	4,021		—		—		4,021
Embedded derivative asset in convertible promissory note	962		—		—		962
Investment in Tyme	6,030		6,030		—		—

Schedule of revenues and accounts receivables by major customers

The total revenues and accounts receivables broken down by major customers as a percentage of the total are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Total revenues
Teva - See Revenue Recognition	36	%	64	%	29	%	65	%
Customer A	19	%	10	%	19	%	9	%
Customer B	7	%	8	%	12	%	8	%
Customer C	12	%	4	%	13	%	4	%
Customer D	7	%	9	%	9	%	10	%
Other	19	%	5	%	18	%	4	%
	100	%	100	%	100	%	100	%

	June 30,		December 31,
	2022		2021
Accounts receivable
Teva - See Revenue Recognition	32	%	63	%
Customer A	21	%	13	%
Customer B	18	%	13	%
Customer C	6	%	2	%
Customer D	4	%	2	%
Other	19	%	7	%
	100	%	100	%

Schedule of dilutive and anti-dilutive common shares equivalents outstanding

The anti-dilutive common share equivalents outstanding for the three and six months ended June 30, 2022 and 2021 were as follows:

	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2021	2022	2021
Stock options	2,499,165	2,844,961	2,092,420	1,622,046
Restricted stock units	77,149	223,103	77,149	1,413,687
Total	2,576,314	3,068,064	2,169,569	3,035,733

Computation for basic and diluted net (loss) earnings per share

The following table sets forth the computation for basic and diluted net (loss) earnings per share for the three and six months ended June 30, 2022 and 2021:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Numerator
Net (loss) income	$	(9,450)	$	3,612	$	34,608	$	3,191
Denominator
Basic weighted average common shares outstanding	12,836,116		13,108,998		12,773,727		13,116,370
Dilutive effect of stock awards	—		153,166		178,061		177,550
Diluted weighted average common shares outstanding	12,836,116		13,262,164		12,951,788		13,293,920
Basic net (loss) earnings per share
Basic net (loss) earnings per share	$	(0.74)	$	0.28	$	2.71	$	0.24
Diluted net (loss) earnings per share
Diluted net (loss) earnings per share	$	(0.74)	$	0.27	$	2.67	$	0.24